Recital 10, Regulation (EU) 2018/1632

In forcesince 30 Oct 2018

In a subsequent application submitted on 3 January 2018, the Applicant made a request to the Commission for protection of proprietary data for a number of studies submitted in support of the application, namely two human clinical studies with a bovine milk basic whey protein isolate [Armor Protéines (2013).] [Schmitt & Mireaux (2008).], an in vitro bacterial reverse mutation assay [Sire, G. (2012a).], an in vitro mammalian cell micronucleus test [Sire, G. (2012b).], a 90-day oral toxicity study in rats [Silvano (2012).], a 6-week developmental toxicity study in juvenile rats, and the electrophoresis analysis of bovine milk basic whey protein isolate [Armor Protéines (2017).].